Qube Research & Technologies Ltd - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 119 filers reported holding IMMUNITYBIO INC in Q2 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q1 2023$45,129
-82.4%
24,796
-51.0%
0.00%
-100.0%
Q4 2022$256,654
-49.2%
50,622
-62.7%
0.00%
-75.0%
Q2 2022$505,000
+74.1%
135,655
+162.1%
0.00%
+100.0%
Q1 2022$290,000
-47.8%
51,765
-43.4%
0.00%
-50.0%
Q4 2021$556,000
-25.5%
91,514
+191.0%
0.00%
-66.7%
Q1 2021$746,00031,4440.01%
Other shareholders
IMMUNITYBIO INC shareholders Q2 2023
NameSharesValueWeighting ↓
ALLEN HOLDING INC /NY 687,571$3,857,0000.50%
ORACLE INVESTMENT MANAGEMENT INC 400,013$2,244,0000.44%
HARBOURVEST PARTNERS LLC 335,709$1,883,0000.38%
Winning Points Advisors, LLC 60,126$339,0000.26%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$541,0000.19%
SHEETS SMITH WEALTH MANAGEMENT 203,876$1,144,0000.16%
Delphia (USA) Inc. 25,504$143,0000.11%
Clearwater Capital Advisors, LLC 147,891$830,0000.10%
Corton Capital Inc. 36,843$207,0000.09%
Virtus ETF Advisers LLC 27,343$153,0000.07%
View complete list of IMMUNITYBIO INC shareholders